Document is current

Any future updates will be listed below

Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies

Crossref DOI link: https://doi.org/10.1007/s40744-022-00529-7

Published Online: 2023-01-20

Published Print: 2023-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark